Communiqués DexCom, Inc.

Actions

DXCM

US2521311074

Equipement, fournitures et distribution médicale

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 18/06/2026			Varia. 5j.	Varia. 1 janv.
72,47 ^USD	+1,74 %		-3,85 %	+9,19 %

16/06	L'intelligence artificielle peut jouer un rôle " significatif » dans les technologies de gestion du diabète, selon David Roman	MT
15/06	DEXCOM, INC. : Piper Sandler réitère son opinion positive sur le titre	ZM

Communiqués

06/06	Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin	BU
04/06	Dexcom Reaffirms CGM Benefits for All People With Diabetes and Continues Momentum Toward Earlier Stage Intervention and Preventative Care at ADA 2026	BU
02/06	Dexcom Releases Customer Advisory Council Report, Outlining Ongoing Commitments to Enhancing Product Performance and User Experience	BU
26/05	Dexcom Uncovers Theft of Scrapped Product, Notifies Potentially Impacted Users	BU
19/05	DexCom : Operations and Innovation Committee	PU
18/05	Redefining CGM for People With Type 2 Diabetes: Dexcom Announces Dexcom Flex in Germany	BU
14/05	Dexcom Announces Governance Enhancements Ahead of 2026 Investor Day	BU
06/05	DexCom : Trade Association Report 2025	PU
05/05	Dexcom to Host Investor Day on May 14, 2026	BU
30/04	DexCom: Q1 Earnings Snapshot	AQ
30/04	Dexcom Reports First Quarter 2026 Financial Results	BU
29/04	Why Medtech Giants Are Quietly Paying Up for AI Diagnostics	AQ
10/04	Did DexCom, Inc. Insiders Breach their Fiduciary Duties to Shareholders?	PR
02/04	Dexcom Schedules First Quarter 2026 Earnings Release and Conference Call for April 30, 2026 at 4:30 p.m. Eastern Time	BU
11/03	Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026	BU
26/02	Dexcom Appoints Rick Osterloh to Board of Directors	BU
26/02	HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS	PR
25/02	Dexcom Announces Upcoming Conference Presentation	BU
12/02	DexCom: Q4 Earnings Snapshot	AQ
12/02	Dexcom Reports Fourth Quarter and Fiscal Year 2025 Financial Results	BU
09/02	Medical Devices: Court Of Appeal Clarifies Novelty Requirements And Claim Interpretation In Latest Abbott v Dexcom Judgment	AQ
04/02	Stelo Adds Enhanced Smart Meal Logging Features as Dexcom Continues to Transform Personal Glucose Management	BU
29/01	HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS	PR
27/01	Dexcom Schedules Fourth Quarter and Fiscal Year 2025 Earnings Release and Conference Call for February 12, 2026 at 4:30 p.m. Eastern Time.	BU
12/01	Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook	BU